RNA interference (RNAi) is a natural cellular defence and regulation mechanism which works by eliminating unwanted RNA molecules. Its potential for use in therapy was officially recognised last year with the presentation of the Nobel Prize in Physiology or Medicine. Indeed, the first treatments to be based on this mechanism are currently undergoing clinical testing.
Nevertheless, the details of this process still require a great deal of further research and hence, offer potential for optimizing medical treatments based on it.
NO RISC. NO FUN.
It is precisely this potential that a group at the Campus Vienna Biocenter recently tapped in order to clarify key details surrounding the efficiency of RNA interference. Lead scientist Dr. Stefan L. Ameres from the Max F.
Perutz Laboratories (MFPL), Department for Biochemistry at the University of Vienna, explains – "A key stage of RNA interference is the binding of the RNA that is to be cleaved by RISC, the RNA-induced silencing complex.
Already a lot is known about the subsequent destruction of the target RNA by RISC, but we have only little insight into the initial determination as to which RNAs are bound and how exactly this happens. Working with the Institute for Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), we have succeeded in making considerable progress towards clarifying this process."
The team initially focussed on characterising the influence of the RNA structure. Variations of an RNA target molecule were created where the RISC binding site became increasingly difficult to access due to structural differences. Dr. Ameres comments on the findings from the experiment: "The results were very clear indeed. The less accessible the binding site, the less efficient the RISC-induced elimination of the target RNA. Based on this data, we concluded that RISC does not possess the means to change the structure of RNA molecules – an important finding towards the effective application of RNAi."Another result was equally important to the understanding of RNA interference. The strength of the interaction between target RNA and RISC must exceed a certain threshold in order to trigger initiation of the subsequent RNA elimination process. This result clearly indicates that RISC binds RNA in a more or less random process and that it is the strength of this bond that determines the subsequent fate of the RNA. "One way of looking at this is that, while binding its target RNA, RISC has to carry out
a check to ensure that it is only certain RNAs that are destroyed," explains Dr. Ameres.
"PH.D. PROGRAM" CAREER OPPORTUNITY
The publication of these results in the journal CELL highlights not just the quality of RNA research at the Max F. Perutz Laboratories (a joint establishment of the University of Vienna and the Medical University of Vienna), but also the high standard of training provided for young scientists in dedicated Ph.D. programs. The publication of these results is also the high point of Dr. Ameres' Ph.D. training, which he has now completed in just this type of program. In fact, a special "RNA Biology" Ph.D. program was established at the Campus Vienna Biocenter in June 2007 to ensure that RNA research there retains its leading position in the long term.
The work of molecular biologist Prof. Renée Schroeder also contributed to this achievement. She supported the work of Dr. Ameres using the prize money from the "Wittgenstein Award" presented to her by the FWF in 2003, thereby making an important financial contribution to the continuation of RNA research at the Campus Vienna Biocenter.
Till C. Jelitto | alfa
A novel socio-ecological approach helps identifying suitable wolf habitats
17.02.2017 | Universität Zürich
New, ultra-flexible probes form reliable, scar-free integration with the brain
16.02.2017 | University of Texas at Austin
In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
17.02.2017 | Medical Engineering
17.02.2017 | Medical Engineering
17.02.2017 | Health and Medicine